Monday, October 28, 2013 6:51:40 AM
Besides, it is not these options they need to worry about. They need to get the other options exercised so that they can get some cash (or clear some debt).
The value of this company will go up with time but management seems to always be more interested in their cut and their ever expanding empire of managers. Their willingness to dilute, the reverse split vote that made no sense at the share price the stock was at (10:1 made more sense if they were really looking for institutional investors instead of simply diluting again) all point to using the stock as a source of working capital for the company and not as a place to reap the rewards of their efforts (and our investments). I will stand by my estimate of $ .36 in twelve (ten) months; maybe not that much if they pull the reverse split. I would really love to be wrong (on the low side). Maybe something will come when they present in November, but I am expecting more of the same. I am not being a pessimist, just a realist.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM